Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	36.27	69.19	48.16	-25	71.52	26.75
Depreciation & Amortization	211.43	169.16	149.26	134.15	68.92	61.55
Other Amortization	5.35	6.02	8.64	8.29	3.41	8.97
Asset Writedown & Restructuring Costs	-	-	-	4.79	-	-
Loss (Gain) From Sale of Investments	-1.48	-2.03	-1.24	-	-	-
Stock-Based Compensation	37.26	32.4	27.14	22.87	24.26	21.91
Other Operating Activities	-16.64	-14.78	21.07	-8.15	-78.02	0.06
Change in Accounts Receivable	15.43	-4.41	3.59	-21.78	-22.52	-10.37
Change in Inventory	6.87	13.93	14.17	48.27	-2.3	-8.27
Change in Accounts Payable	1.82	-11.28	5.06	-0.71	-5.83	3.77
Change in Other Net Operating Assets	-92.83	-53.21	-1.09	-38.5	44.13	-10.43
Operating Cash Flow	203.48	204.98	274.75	124.23	103.56	93.94
Operating Cash Flow Growth	-26.46%	-25.39%	121.16%	19.96%	10.23%	238.13%
Capital Expenditures	-1.68	-1.65	-0.46	-1.62	-1.94	-5.55
Cash Acquisitions	-267.54	-267.54	-	-572.07	-	-
Sale (Purchase) of Intangibles	-	-	-	-	-	-368.23
Investment in Securities	-4.11	-18.57	-70.35	-	-	-
Investing Cash Flow	-273.32	-287.76	-70.81	-573.69	-1.94	-373.77
Long-Term Debt Issued	-	325	241.5	517.68	-	338.32
Total Debt Issued	325	325	241.5	517.68	-	338.32
Long-Term Debt Repaid	-	-305.66	-301.14	-75	-50	-49
Net Debt Issued (Repaid)	111.94	19.34	-59.64	442.68	-50	289.32
Issuance of Common Stock	3.16	11.07	9.1	12.15	12.71	7.34
Repurchase of Common Stock	-61.57	-79.2	-83.36	-18.11	-52.01	-2.26
Other Financing Activities	-19.38	-11.83	-6.28	-	-	-7.93
Financing Cash Flow	34.15	-60.6	-140.18	436.72	-89.3	286.47
Net Cash Flow	-35.69	-143.38	63.76	-12.74	12.31	6.64
Free Cash Flow	201.81	203.33	274.29	122.61	101.61	88.4
Free Cash Flow Growth	-26.78%	-25.87%	123.71%	20.66%	14.95%	314.13%
Free Cash Flow Margin	28.54%	32.20%	48.39%	26.43%	36.70%	28.51%
Free Cash Flow Per Share	5.07	5.03	6.56	3.62	2.48	2.52
Cash Interest Paid	68.43	62.43	73.26	52.53	17.61	18.97
Cash Income Tax Paid	48.48	52.09	24.21	10.4	3.01	0.48
Levered Free Cash Flow	336.48	362.08	274.32	70.53	109.21	-288.37
Unlevered Free Cash Flow	382.57	402.3	317.77	101.75	118.93	-279.29
Change in Working Capital	-68.71	-54.98	21.73	-12.71	13.49	-25.3

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q